Linda Levi
Tel Litwinsky, TA 52621, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Cognitive decline in psychotic disorders: A longitudinal matched case-control study.
Journal: Schizophrenia research. Cognition
Published: May 13, 2026
Intranasal Oxytocin Combined With Social Skills Training for Schizophrenia: An Add-on Randomized Controlled Trial.
Journal: Schizophrenia bulletin open
Published: November 06, 2024
Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE Study.
Journal: Schizophrenia bulletin
Published: March 31, 2023
A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: January 04, 2023
Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial.
Journal: The Journal of clinical psychiatry
Published: August 03, 2022
COVID-19 and severe mental illness in Israel: testing, infection, hospitalization, mortality and vaccination rates in a countrywide study.
Journal: Molecular psychiatry
Published: January 07, 2022
Familial clustering of psychiatric disorders and low IQ.
Journal: Psychological medicine
Published: December 16, 2021
Means of suicide in psychiatric patients: Population-based data from Israel between 2001 and 2020.
Journal: Schizophrenia research
Published: October 30, 2021
Differences in Antipsychotic Treatment Discontinuation Among Veterans With Schizophrenia in the U.S. Department of Veterans Affairs.
Journal: The American journal of psychiatry
Published: July 14, 2021
Misreporting of Results of Research in Psychiatry.
Journal: Schizophrenia bulletin
Published: April 16, 2021
Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials.
Journal: Schizophrenia bulletin
Published: January 22, 2021
The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: January 15, 2021
Last Updated: 09/26/2026